US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% NVDA $233.95 ▲+0.00% SNDK $1,719.99 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% SDEV $7.48 ▲+0.00% WDC $415.29 ▲+0.00%
FinancialContent

Articles published by Profusa, Inc.

News headline image
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa, Inc. Receives Nasdaq Compliance Determination
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Announces 1-for-4 Reverse Stock Split
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Announces 1-for-25 Reverse Stock Split
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Submits Response Package to GMED as Part of Ongoing CE Mark Review Process for Lumee® Oxygen Platform
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Announces Listing Transfer to The Nasdaq Capital Market
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Receives Favorable Nasdaq Listing Determination
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Announces 1-for-75 Reverse Stock Split
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Adds Leading Greek Vascular Surgeon to Customer Base
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Bolsters European Commercial Network with New French Distributor, MedSell
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Announces Third Quarter Business and Financial Highlights
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA
News headline image
Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches
From Profusa, Inc.
Via GlobeNewswire
Tickers PFSA